Lifetime cost-effectiveness of rosiglitazone/metformin fixed dose combination for the treatment of type 2 diabetes in Portugal

被引：0
|
作者：
Taylor, M.
Shearer, A.
Bagust, A.
Vaz, J. P.
Pereira, J.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A548 / A548
页数：1
相关论文
共 50 条
  • [1] Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain
    Shearer A.T.
    Bagust A.
    Ampudia-Blasco F.J.
    Álvarez B.M.-L.
    Escolano I.P.
    París G.
    [J]. PharmacoEconomics, 2006, 24 (Suppl 1) : 49 - 59
  • [2] Lifetime cost-effectiveness of rosiglitazone-metformin combination in obese patients with Type 2 diabetes in Germany
    Goertz, A
    Shearer, A
    Bagust, A
    Schoeffski, O
    Liebl, A
    [J]. DIABETOLOGIA, 2004, 47 : A356 - A356
  • [3] Cost-effectiveness in Germany of rosiglitazone-metformin combination in Type 2 diabetes.
    Bagust, A
    Shearer, A
    Schoeffski, O
    Reitberger, U
    Goertz, A
    Behrens, M
    [J]. DIABETOLOGIA, 2003, 46 : A444 - A444
  • [4] COST-EFFECTIVENESS OF FIXED-DOSE COMBINATION (FDC) OF VILDAGLIPTIN/METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 IN MEXICO
    Lemus, A.
    Jimenez Aranda, P.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A689 - A689
  • [5] Cost-effectiveness of rosiglitazone-metformin combination in overweight patients with type 2 diabetes in Germany
    Shearer, A
    Bagust, A
    Schoeffski, O
    Reitberger, U
    Goertz, A
    Behrens, M
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 607 - 607
  • [6] Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany
    Shearer A.T.
    Bagust A.
    Liebl A.
    Schoeffski O.
    Goertz A.
    [J]. PharmacoEconomics, 2006, 24 (Suppl 1) : 35 - 48
  • [7] Clinical and cost-effectiveness of Rosiglitazone-Metformin combination in patients with Type-2 Diabetes in Spain
    Shearer, A
    Bagust, A
    Ampudia-Blasco, J
    Martinez-Lage, B
    [J]. DIABETES, 2004, 53 : A293 - A293
  • [8] Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK
    Sophie Beale
    Adrian Bagust
    Arran T. Shearer
    Alan Martin
    Lisa Hulme
    [J]. PharmacoEconomics, 2006, 24 (Suppl 1) : 21 - 34
  • [9] COST-EFFECTIVENESS OF ROSIGLITAZONE COMBINATION THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES IN THE CZECH REPUBLIC
    Dolezal, T.
    Skoupa, J.
    Taylor, M. J.
    Whitehead, S.
    Rausova, V
    Pavlikova, P.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A504 - A504
  • [10] The cost-effectiveness of pioglitazone in combination with metformin in the treatment of type 2 diabetes mellitus in Scotland
    Stynes, G
    Tilden, D
    Swift, M
    Cockle, S
    Haycox, A
    Aristides, M
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 737 - 738
12345